Therapeutic dendritic cell vaccine preparation using tumor RNA transfection: a promising approach for the treatment of prostate cancer
/in International Publications, Prostate Cancer /von 2008-01-18 / Genet Vaccines Ther 2008 Jan;6:2Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes
/in International Publications, Newcastle Disease Virus /von 2008-01-17 / Gene Ther. 2008 Mar;15(5):371-83Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia
/in Acute Leukemia, International Publications /von 2008-01-15 / Transfusion 2008 May;48(5):861-70Dendritic cells transduced with a PSMA-encoding adenovirus and cocultured with autologous cytokine-induced lymphocytes induce a specific and strong immune response against prostate cancer cells
/in International Publications, Prostate Cancer /von 2008-01-14 / Urol. Oncol. 2009 Jan-Feb;27(1):26-32Monocyte derived dendritic cells retain their functional capacity in patients following infection with hepatitis C virus
/in Chronic Virus Hepatitis, International Publications /von 2008-01-10 / J. Viral Hepat. 2008 Mar;15(3):219-28Modulation of viability and maturation of human monocyte-derived dendritic cells by oncolytic adenoviruses
/in International Publications, Malignant Melanoma /von 2008-01-01 / Int. J. Cancer 2008 Jan;122(1):219-29Prostate cancer vaccines: current status and future potential
/in International Publications, Prostate Cancer /von 2008-01-01 / BioDrugs 2008;22(2):71-84Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes
/in International Publications, Pancreatic Cancer /von 2008-01-01 / Anticancer Res. 2008 Jan-Feb;28(1B):379-87Immunotherapeutic approaches in pancreatic cancer
/in International Publications, Pancreatic Cancer /von 2008-01-01 / Recent Results Cancer Res. 2008;177:165-77IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de